Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 8
Submit an article Journal homepage
337
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Lenalidomide maintenance after second autologous stem cell transplant improves overall survival in multiple myeloma

Dipenkumar ModiDepartment of Oncology, Blood and Marrow Stem Cell Transplant Program, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA; Correspondence[email protected] [email protected]
,
Jie ChiDepartment of Internal Medicine, Wayne State University, Detroit, MI, USA;
,
Seongho KimDepartment of Oncology, Biostatistics Core, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA
,
Lois AyashDepartment of Oncology, Blood and Marrow Stem Cell Transplant Program, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA;
,
Asif AlaviDepartment of Oncology, Blood and Marrow Stem Cell Transplant Program, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA;
,
Andrew KinDepartment of Oncology, Blood and Marrow Stem Cell Transplant Program, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA;
,
Voravit RatanatharathornDepartment of Oncology, Blood and Marrow Stem Cell Transplant Program, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA;
,
Joseph P. UbertiDepartment of Oncology, Blood and Marrow Stem Cell Transplant Program, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA;
&
Abhinav DeolDepartment of Oncology, Blood and Marrow Stem Cell Transplant Program, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA;
show all
Pages 1877-1884 | Received 06 Dec 2019, Accepted 20 Mar 2020, Published online: 09 Apr 2020

References

  • Child JA, Morgan GJ, Davies FE, et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med. 2003;348:1875–1883.
  • Attal M, Harousseau JL, Facon T, et al. Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med. 2003;349:2495–2502.
  • Attal M, Harousseau JL, Stoppa AM, et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med. 1996;335:91–97.
  • Attal M, Lauwers-Cances V, Marit G, et al. Lenalidomide maintenance after stem-cell transplantation for multiple myeloma. N Engl J Med. 2012;366:1782–1791.
  • McCarthy PL, Owzar K, Hofmeister CC, et al. Lenalidomide after stem-cell transplantation for multiple myeloma. N Engl J Med. 2012;366:1770–1781.
  • Palumbo A, Cavallo F, Gay F, et al. Autologous transplantation and maintenance therapy in multiple myeloma. N Engl J Med. 2014;371:895–905.
  • McCarthy PL, Holstein SA, Petrucci MT, et al. Lenalidomide maintenance after autologous stem-cell transplantation in newly diagnosed multiple myeloma: a meta-analysis. J Clin Oncol. 2017;35:3279–3289.
  • Goldschmidt H, Lokhorst HM, Mai EK, et al. Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial. Leukemia. 2018;32:383–390.
  • Dimopoulos MA, Gay F, Schjesvold F, et al. Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial. Lancet. 2019;393:253–264.
  • Jimenez-Zepeda VH, Mikhael J, Winter A, et al. Second autologous stem cell transplantation as salvage therapy for multiple myeloma: impact on progression-free and overall survival. Biol Blood Marrow Transplant. 2012;18:773–779.
  • Sellner L, Heiss C, Benner A, et al. Autologous retransplantation for patients with recurrent multiple myeloma: a single-center experience with 200 patients. Cancer. 2013;119:2438–2446.
  • Gonsalves WI, Gertz MA, Lacy MQ, et al. Second auto-SCT for treatment of relapsed multiple myeloma. Bone Marrow Transplant. 2013;48:568–573.
  • Lemieux E, Hulin C, Caillot D, et al. Autologous stem cell transplantation: an effective salvage therapy in multiple myeloma. Biol Blood Marrow Transplant. 2013;19:445–449.
  • Singh Abbi KK, Zheng J, Devlin SM, et al. Second autologous stem cell transplant: an effective therapy for relapsed multiple myeloma. Biol Blood Marrow Transplant. 2015;21:468–472.
  • Cook G, Liakopoulou E, Pearce R, et al. Factors influencing the outcome of a second autologous stem cell transplant (ASCT) in relapsed multiple myeloma: a study from the British Society of Blood and Marrow Transplantation Registry. Biol Blood Marrow Transplant. 2011;17:1638–1645.
  • Michaelis LC, Saad A, Zhong X, et al. Salvage second hematopoietic cell transplantation in myeloma. Biol Blood Marrow Transplant. 2013;19:760–766.
  • Parrish C, Rahemtulla A, Cavet J, et al. Autologous stem cell transplantation is an effective salvage therapy for primary refractory multiple myeloma. Biol Blood Marrow Transplant. 2015;21:1330–1334.
  • Atanackovic D, Schilling G. Second autologous transplant as salvage therapy in multiple myeloma. Br J Haematol. 2013;163:565–572.
  • Fenk R, Liese V, Neubauer F, et al. Predictive factors for successful salvage high-dose therapy in patients with multiple myeloma relapsing after autologous blood stem cell transplantation. Leuk Lymphoma. 2011;52:1455–1462.
  • Mian I, Milton DR, Shah N, et al. Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma. Cancer. 2016;122:3831–3837.
  • Andersen E, Videbaek A. Stem cell leukaemia in myelomatosis. Scand J Haematol. 1970;7:201–207.
  • Kyle RA, Pierre RV, Bayrd ED. Multiple myeloma and acute myelomonocytic leukemia. N Engl J Med. 1970;283:1121–1125.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.